SynGen

About:

SynGen produces advanced cell separation tools and accessories to support regenerative medicine workflows.

Website: http://syngeninc.com

Top Investors: GE Capital, Bay City Capital

Description:

SynGen enables regenerative cures through innovative engineering. The company invents and commercializes products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices to isolate and capture stem and progenitor cells from peripheral and umbilical cord blood, bone marrow, and adipose tissue. Their products provide an important enabling platform for use in diagnostic, research, and clinical processes. Their inventions are based upon interdisciplinary fields that apply principles of engineering and life sciences to develop solutions required for regenerative medicine.